Leadership & Pay ·
AbbVie director Jennifer L. Davis resigns effective Nov 2 to become CEO at Align Technology
ABBVAbbVie Inc.
Jennifer L. Davis notified AbbVie's Board of Directors on October 28, 2026, of her intent to resign from the board, effective November 2, 2026. Her departure follows her recent appointment as Chief Executive Officer at Align Technology, Inc. The company stated that the resignation is not the result of any dispute or disagreement with AbbVie regarding its operations, policies, or practices. AbbVie operates in the pharmaceutical industry, developing and commercializing innovative medicines.